Lattice Biologics Ltd LBLTF

Primary Symbol: V.LBL.H

Healthcare Biotechnology

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

TSXV:LBL.H - Post by User

Lattice Biologics Ltd > Reduced expenses - not

<< Previous

Bullboard Posts

Next >>

Comment by Eastcoast50on Feb 02, 2021 8:32pm

81 Views

Post# 32454238

RE:Reduced expenses - not

Even in this low interest environment he estimates rates of 10%. Creditors have him over a barrel

nothinghere wrote: Guy said he reduced operating expenses.

Other income (expense): Interest and finance charges..

2020 (1,146,763) 2019 (447,356) Net loss and comprehensive

He actually increased expenses by almost a million dollars.